Effectiveness of PRP Pharmacopuncture for Chronic Neck Pain in Cervical Myofascial Syndrome of the Upper Trapezius
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-59
SponsorIndonesia University
About this trial
The goal of this clinical trial is to learn whether pharmacopuncture with Platelet-Rich Plasma (PRP) is effective for treating chronic neck pain in cervical myofascial syndrome related to the upper trapezius muscle. The main questions it aims to answer are:
1. Is pharmacopuncture with Platelet-Rich Plasma (PRP) effective in reducing chronic neck pain in patients with cervical myofascial syndrome related to the upper trapezius muscle? 2. Does PRP pharmacopuncture improve functional outcomes and quality of life in these patients? 3. Are there any adverse effects associated with PRP pharmacopuncture in this context?
Researchers will compare PRP pharmacopuncture to normal saline pharmacopuncture (placebo) to evaluate whether PRP provides greater effectiveness in reducing chronic neck pain in cervical myofascial syndrome related to the upper trapezius muscle.
Participants will:
* Receive a single session of pharmacopuncture therapy * Undergo evaluations at week 2, week 4, and week 8 after the intervention
Eligibility criteria
Qualifiers
Male or female, aged 18 to 59 years.
Experiencing neck pain for more than 3 months (chronic).
Neck pain classified as Grade I to III according to the Neck Pain Task Force classification.
Presence of referred pain pattern on physical examination consistent with the distribution of the upper trapezius muscle.
Disqualifiers
Hemoglobin level <13 g/dL for males or <12 g/dL for females.
Platelet count <150,000/μL.
Presence of fever (≥37.5°C).
Diagnosis of fibromyalgia.
Trial design
Treatments tested in this trial
- PRP Pharmacopuncture
- Placebo Pharmacopuncture
Treatment groups
72 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov